Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
UroGen Pharma Ltd. (URGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"UroGen Pharma Reports Record JELMYTO Quarterly Sales and Recent Corporate Developments"
05/11/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"UroGen Pharma Meets Revenue Goal, Reports First Quarter 2023 Financial Results and Recent Corporate Developments"
03/22/2023 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"UroGen Pharma Reports Highest Revenue Quarter and Significant Full Year 2022 Growth and Recent Corporate Developments",
"Excerpt of transcript from conference call held on March 16, 2023"
11/10/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"UroGen Pharma Reports Third Quarter 2022 Financial Results and Recent Corporate Developments"
08/11/2022 8-K Quarterly results
05/10/2022 8-K Quarterly results
03/21/2022 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Employment Agreement between the Company and Dong Kim",
"UroGen Pharma Reports Fourth Quarter and Full-year 2021 Financial Results and Recent Corporate Developments"
11/15/2021 8-K Quarterly results
Docs: "UroGen Pharma Reports Third Quarter 2021 Financial Results and Recent Corporate Developments"
08/04/2021 8-K Quarterly results
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"UroGen Pharma Reports Second Quarter 2021 Financial Results and Recent Corporate Developments"
03/18/2021 8-K Quarterly results
11/09/2020 8-K Quarterly results
Docs: "UroGen Pharma Reports Third Quarter 2020 Financial Results and Recent Corporate Developments Top-line Results from UGN-102 OPTIMA II Phase 2b Trial Expected by Year End 2020; On Track to Initiate Phase 3 ATLAS Trial by Year End"
08/10/2020 8-K Quarterly results
11/12/2019 8-K Quarterly results
08/09/2019 8-K Quarterly results
05/09/2019 8-K Quarterly results
Docs: "UroGen Pharma Reports First Quarter 2019 Financial Results and Recent Corporate Developments"
02/28/2019 8-K Quarterly results
11/14/2017 6-K Quarterly results
Docs: "6-K",
"Unaudited Condensed Consolidated Interim Financial Statements as of and for the Nine Months ended September 30, 2017",
"Management's Discussion and Analysis of Financial Condition and Results of Operations as of and for the Nine Months ended September 30, 2017",
"UroGen Pharma Reports Third Quarter 2017 Financial Results and Recent Corporate Developments"
08/14/2017 6-K Quarterly results

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy